Novo Nordisk A/S stock price
NVO
#58

46,00 $
  

2.52%

Novo Nordisk A/S Info

Capitalización de mercado
204,1B $

2.52%

Volumen diario
1,03B $
Tipo de activo
Acciones
Empleados
78387
Fundado
Dec 21, 1923
Exchange principal
New York Stock Exchange
Número CIK
0000353278

Datos de acciones tokenizadas

Prom. del precio tokenizado
47,02 $
Diferencia de precio
+1,01 $(+2.21%)
Capitalización de mercado tokenizada
3,82M $

3.57%

Volumen tokenizado (24h)
1,21M $

26.35%

Emisores
Contratos
Exploradores
Convertidor de NVO a USD
NVO
USD
Rendimiento de precios
Baja
44,7 $
Alta
48,58 $

Cargando datos

Por favor, espera, estamos cargando datos de gráficos

Novo Nordisk A/S comunidad

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Datos de Precio en vivo

The current price of Novo Nordisk A/S in the market is 46 $, with a 24-hour trading volume of 1,03B $. The asset's market cap is 204,1B $, after moving 2.53% in the last day.

Tokenized Novo Nordisk A/S is trading at 47,02 $, with a tokenized market cap of 3,82M $ and a 24-hour trading volume of 1,21M $. The tokenized asset has moved 3.58% in the past 24 hours.